A study to compare different doses of fenebrutinib with a “placebo” – in patients with lupus
Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Autoimmune Disorder Systemic Lupus Erythematosus
For the latest version of this information please go to www.forpatients.roche.com